Hazard-based risk grouping effectively stratifying breast cancer patients in post-irradiation long-term heart diseases: a population-based cohort study

Hazard-based risk grouping effectively stratifying breast cancer patients in post-irradiation long-term heart diseases: a population-based cohort study

BackgroundEven though advanced radiotherapy techniques provide a better protective effect on surrounding normal tissues, the late sequelae from radiation exposure to the heart are still considerable in breast cancer patients. The present population-based study explored the role of cox-regression-bas...

Full description

Bibliographic Details
Main Authors:	Moon-Sing Lee, Wei-Ta Tsai, Hsuan-Ju Yang, Shih-Kai Hung, Wen-Yen Chiou, Dai-Wei Liu, Liang-Cheng Chen, Chia-Hui Chew, Ben-Hui Yu, Feng-Chun Hsu, Tung-Hsin Wu, Hon-Yi Lin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	synergic effect heart failure cardiovascular disease breast cancer epirubicin radiotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.980101/full

Similar Items

Emerging Challenges of Radiation-Associated Cardiovascular Dysfunction (RACVD) in Modern Radiation Oncology: Clinical Practice, Bench Investigation, and Multidisciplinary Care
by: Moon-Sing Lee, et al.
Published: (2020-02-01)

Effectiveness of individual audio-visual coaching, respiratory modulated stereotactic body radiotherapy for localized hepatocellular carcinoma: Analysis of 29 cases from a single academic radiotherapy center
by: Liang-Cheng Chen, et al.
Published: (2021-01-01)

Clinical outcomes of benign brain tumors treated with single fraction LINAC-based stereotactic radiosurgery: Experience of a single institute
by: Chia-Hui Chew, et al.
Published: (2022-01-01)

Association of spironolactone use with risk of urinary tract cancer in the general population: A matched population-based cohort study
by: Liang-Cheng Chen, et al.
Published: (2024-01-01)

Effect of metformin alone and in combination with etoposide and epirubicin on proliferation, apoptosis, necrosis, and migration of B-CPAP and SW cells as thyroid cancer cell lines
by: Ghazaleh Ghavami, et al.
Published: (2023-01-01)

Prognosticators of hepatocellular carcinoma with intrahepatic vascular invasion
by: Yuan-Chen Lo, et al.
Published: (2019-01-01)

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial
by: Liang-Cheng Chen, et al.
Published: (2019-03-01)

Molecular subtypes of breast cancer predicting clinical benefits of radiotherapy after breast-conserving surgery: a propensity-score-matched cohort study
by: Shih-Kai Hung, et al.
Published: (2023-12-01)

A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy
by: Ching-Wen Liu, et al.
Published: (2016-06-01)

Andrographolide enhances the anti-metastatic effect of radiation in Ras-transformed cells via suppression of ERK-mediated MMP-2 activity.
by: Chih-Chia Yu, et al.
Published: (2018-01-01)

Clinical and pathologic factors affecting lymph node yields in colorectal cancer.
by: Ta-Wen Hsu, et al.
Published: (2013-01-01)

Survival rate in nasopharyngeal carcinoma improved by high caseload volume: a nationwide population-based study in Taiwan
by: Chou Pesus, et al.
Published: (2011-08-01)

The incidence of venous thromboembolism in cervical cancer: a nationwide population-based study
by: Tsai Shiang-Jiun, et al.
Published: (2012-06-01)

High incidence of ischemic stroke occurrence in irradiated lung cancer patients: a population-based surgical cohort study.
by: Shih-Kai Hung, et al.
Published: (2014-01-01)

IRAK2, an IL1R/TLR Immune Mediator, Enhances Radiosensitivity via Modulating Caspase 8/3-Mediated Apoptosis in Oral Squamous Cell Carcinoma
by: Chih-Chia Yu, et al.
Published: (2021-06-01)

Epirubicin-induced Kounis syndrome
by: Hui-zhu Liang, et al.
Published: (2021-03-01)

IRAK2, an Immune and Radiation-Response Gene, Correlates with Advanced Disease Features but Predicts Higher Post-Irradiation Local Control in Non-Metastatic and Resected Oral Cancer Patients
by: Chih-Chia Yu, et al.
Published: (2023-04-01)

Buccal mucosa carcinoma: surgical margin less than 3 mm, not 5 mm, predicts locoregional recurrence
by: Chiou Wen-Yen, et al.
Published: (2010-09-01)

Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical application
by: Hon-Yi Lin, et al.
Published: (2023-05-01)

Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome
by: Lin Hon-Yi, et al.
Published: (2010-03-01)

Effect of Epirubicin Against Glioma Initiating Cells
by: Atsushi Nakajima, et al.
Published: (2020-11-01)

Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma
by: Ming-Yen Hsieh, et al.
Published: (2011-10-01)

Development of R8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer
by: Jing-Jing Liu, et al.
Published: (2019-12-01)

Effects of HepaSphere microsphere encapsule epirubicin with a new loading method transarterial chemoembolization: in vitro and in vivo experiments
by: Wen Zhang, et al.
Published: (2023-11-01)

Protective Effects of Hesperetin on Cardiomyocyte Integrity and Cytoskeletal Stability in a Murine Model of Epirubicin-Induced Cardiotoxicity: A Histopathological Study
by: Adina Pop Moldovan, et al.
Published: (2024-03-01)

Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2–3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells
by: Juang V, et al.
Published: (2016-11-01)

The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
by: Deyue Liu, et al.
Published: (2022-06-01)

Efficacy and Safety of Epirubicin Combined with Temozolomide for Treatment of Advanced Leiomyosarcoma
by: Tan H, et al.
Published: (2021-12-01)

Chronic obstructive pulmonary disease with short-acting inhaled pharmacotherapy increases the risk of prostate cancer: A two-stage database approach.
by: Hui-Wen Lin, et al.
Published: (2018-01-01)

One-Pot Synthesis of Epirubicin-Capped Silver Nanoparticles and Their Anticancer Activity against Hep G2 Cells
by: Jun Ding, et al.
Published: (2019-03-01)

A Physiologically Based Pharmacokinetic Model to Predict Determinants of Variability in Epirubicin Exposure and Tissue Distribution
by: Radwan Ansaar, et al.
Published: (2023-04-01)

Involvement of intracellular cAMP in epirubicin-induced vascular endothelial cell injury
by: Takaaki Yamada, et al.
Published: (2016-01-01)

Long-term patient-reported donor-site morbidity after free peroneal fasciocutaneous flap in head and neck reconstruction
by: Shih-Yu Lee, et al.
Published: (2023-07-01)

The chemosensitizer ferulic acid enhances epirubicin-induced apoptosis in MDA-MB-231 cells
by: Wei-Jia Cheng, et al.
Published: (2020-10-01)

Anti-Tumor Effect of Apatinib and Relevant Mechanisms in Liposarcoma
by: Lixuan Cui, et al.
Published: (2021-11-01)

Codelivery of Anticancer Drug and Photosensitizer by PEGylated Graphene Oxide and Cell Penetrating Peptide Enhanced Tumor-Suppressing Effect on Osteosarcoma
by: Yi-Fei Zhang, et al.
Published: (2021-03-01)

The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo
by: Ning Xu, et al.
Published: (2019-03-01)

Metformin Alleviates Epirubicin-Induced Endothelial Impairment by Restoring Mitochondrial Homeostasis
by: Qi Sun, et al.
Published: (2022-12-01)

Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients
by: Hui-Ju Tsai, et al.
Published: (2021-03-01)

Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer
by: Chin-Chia Wu, et al.
Published: (2023-11-01)